Gene · 4041
Papers4,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 4,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of the Interleukin-6 Receptor Blocker Sarilumab on Metabolic Activity and Differentiation Capacity of Primary Human Osteoblasts. | Pharmaceutics | 2022 | 35890286 | PubTator, text mining | PubMed |
| Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma. | Pharmaceutics | 2022 | 35890276 | PubTator, text mining | PubMed |
| Altered Transcriptional Regulation of Glycolysis in Circulating CD8+ T Cells of Rheumatoid Arthritis Patients. | Genes (Basel) | 2022 | 35886000 | PubTator, text mining | PubMed |
| Mutation spectrum in a cohort with familial exudative vitreoretinopathy. | Mol Genet Genomic Med | 2022 | 35876299 | PubTator, text mining | PubMed |
| Application of Small Molecules in the Central Nervous System Direct Neuronal Reprogramming. | Front Bioeng Biotechnol | 2022 | 35875485 | PubTator, text mining | PubMed |
| Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies. | Front Pharmacol | 2022 | 35873564 | PubTator, text mining | PubMed |
| Transforming growth factor-β signaling governs the differentiation program of extravillous trophoblasts in the developing human placenta. | Proc Natl Acad Sci U S A | 2022 | 35867736 | PubTator, text mining | PubMed |
| Drugs in Clinical Development to Treat Autosomal Dominant Polycystic Kidney Disease. | Drugs | 2022 | 35852784 | PubTator, text mining | PubMed |
| High-throughput techniques enable advances in the roles of DNA and RNA secondary structures in transcriptional and post-transcriptional gene regulation. | Genome Biol | 2022 | 35851062 | PubTator, text mining | PubMed |
| Tumor specificity of WNT ligands and receptors reveals universal squamous cell carcinoma oncogenes. | BMC Cancer | 2022 | 35850748 | PubTator, text mining | PubMed |
| Decoding the Mechanism of Shixiao Powder in Treating Coronary Heart Disease Based on Network Pharmacology and Molecular Docking. | Evid Based Complement Alternat Med | 2022 | 35845584 | PubTator, text mining | PubMed |
| The Mechanism of Wnt Pathway Regulated by Telocytes to Promote the Regeneration and Repair of Intrauterine Adhesions. | Comput Math Methods Med | 2022 | 35844454 | PubTator, text mining | PubMed |
| An LRP6 mutation (Arg360His) associated with low bone mineral density but not cardiovascular events in a Caucasian family. | Osteoporos Int | 2022 | 35840698 | PubTator, text mining | PubMed |
| WNT signaling and cancer stemness. | Essays Biochem | 2022 | 35837811 | PubTator, text mining | PubMed |
| The mechanistic pathways of oxidative stress in aortic stenosis and clinical implications. | Theranostics | 2022 | 35836811 | PubTator, text mining | PubMed |
| Transcutaneous Electrical Acupoint Stimulation for Moderate to Severe Pain in Hepatocellular Carcinoma: A Protocol for a Randomized Controlled Trial. | J Pain Res | 2022 | 35832212 | PubTator, text mining | PubMed |
| Genotype-phenotype associations in familial exudative vitreoretinopathy: A systematic review and meta-analysis on more than 3200 individuals. | PLoS One | 2022 | 35830446 | PubTator, text mining | PubMed |
| The role of the Wnt signalling pathway in the energy metabolism of bone remodelling. | Cell Prolif | 2022 | 35811348 | PubTator, text mining | PubMed |
| Sclerostin in Excessive Drinkers: Relationships with Liver Function and Body Composition. | Nutrients | 2022 | 35807755 | PubTator, text mining | PubMed |
| GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review. | Int J Mol Sci | 2022 | 35806376 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4041/papers?page=39